The data presented below was compiled using a Screener widget and a Newsfeed widget on the Benzinga Pro platform. The Screener is customizable and is available for the pre-market and after-hours sessions in addition the the intraday session. To try out these widgets, sign up for a trial of the Benzinga Pro platform.
Percentage changes in prices below refer to total weekly change.
Biggest Gainers
- Seadrill Ltd SDRL - Gained 89.7 percent on high trading volume despite no company-specific or fundamental news.
- ADOMANI Inc ADOM - Gained 83.4 percent on Friday alone; No formal news regarding the company.
- VIVUS Inc VVUS - Shares up 48.8 percent for the week after the company received letter from Nasdaq regarding continued listing subject to certain conditions; The company must have effected reverse stock split, evidenced closing bid by October 1.
- VAALCO Energy Inc EGY - Up 40.7 percent in sympathy with other energy and petroleum stocks after Thursday news of oil rebound.
- Black Box Corp BBOX - Up 39.2 percent despite no company-specific news.
Biggest Losers
- Agile Therapeutics Inc AGRX - Down 75 percent after the FDA on Friday announced significant concerns regarding the company’s Twirla contraceptive.
- Cesca Therapeutics Inc KOOL - Down 52.8 percent. The company on Monday reported Q1 EPS and Sales down YoY, and on Wednesday priced a ~9.2 million share offering at 60 cents per share. With ~11.5 million shares outstanding, it could also be attracting low-float interest.
- Netshoes (Cayman) Ltd NETS - Down 48.8 percent. The company reported a Q1 earnings miss on Monday and was downgraded by JPMorgan on Wednesday.
- ATyr Pharma Inc LIFE - Down 39.8 percent. The company on Monday reported a Q1 miss and announced it would undergo a restructuring, including a 30-percent workforce reduction.
- Jounce Therapeutics Inc JNCE - Down 34.9 percent after a ASCO abstract released Wednesday. Abstract showed the company’s JTX-2011 0.3mg/kg had 'no substantial change in number of peripheral Teff or Tregs'.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in